| abstract |
(57) [Summary] [PROBLEMS] An anticancer agent, an autoimmune disease therapeutic agent and a QOL-improved anticancer agent having low side effects due to continuous administration and high efficacy, Provide a therapeutic agent for infectious diseases. The present invention provides an anticancer agent, a therapeutic agent for an autoimmune disease, and a therapeutic agent for an infectious disease comprising a carbamoyl derivative represented by the formula as an active ingredient. [Effect] A new type of anticancer agent, therapeutic agent for autoimmune disease, therapeutic agent for infectious disease, which has few side effects due to continuous administration, and has high cell growth inhibitory activity, anticancer activity and a wide safety margin, is provided. |